According to our (Global Info Research) latest study, the global Peramivir Intermediate market size was valued at US$ 7.17 million in 2025 and is forecast to a readjusted size of US$ 11.26 million by 2032 with a CAGR of 6.6% during review period.
In 2025, based on a combined calculation of multiple route intermediates, the global sales volume of Peramivir Intermediate was approximately 45 tons, with an average global market price of about USD 155/kg. The gross margin of major producers in the industry was approximately 30%-50%.
Peramivir Intermediate refers to a group of specialized organic synthesis intermediates formed around the construction of the peramivir molecular skeleton. It is not a single fixed compound, but includes multiple route intermediates with different structures and CAS numbers. These products generally feature structural characteristics such as chiral cyclopentane, cyclopentene, isoxazole, Boc-protected amino groups, carboxylate esters, and hydroxy amino groups. Their synthesis typically involves chiral control, introduction and removal of protecting groups, functional group transformation, selective reduction, esterification, or hydrolysis. Due to structural differences among intermediates at different route stages, their appearance, purity, impurity profile, stability, and storage conditions may vary.
The upstream industry chain of Peramivir Intermediate mainly includes chiral cyclopentene/cyclopentane raw materials, guanidination reagents, Boc protection reagents, carboxylate esterification reagents, solvents, catalysts, reducing agents, and acid-base reagents. Downstream, it is mainly used to produce peramivir API, which can be further processed into peramivir trihydrate or finished dosage forms such as peramivir injection.
This report is a detailed and comprehensive analysis for global Peramivir Intermediate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Peramivir Intermediate market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Peramivir Intermediate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Peramivir Intermediate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Peramivir Intermediate market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Peramivir Intermediate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Peramivir Intermediate market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PharmaResources, Jinan Jianfeng Chemical, Shandong Kelikang Pharmaceutical, Jiangsu Zenji Pharmaceuticals, Jinan Gongchuang Pharmaceutical Technology, Ruifu Chemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Peramivir Intermediate market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Medicine Grade
Chemical Grade
Market segment by Synthesis Stage
Early Stage
Middle Stage
Late Stage
Market segment by Application
Pharmaceuticals
Scientific Research
Other
Major players covered
PharmaResources
Jinan Jianfeng Chemical
Shandong Kelikang Pharmaceutical
Jiangsu Zenji Pharmaceuticals
Jinan Gongchuang Pharmaceutical Technology
Ruifu Chemical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peramivir Intermediate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Peramivir Intermediate, with price, sales quantity, revenue, and global market share of Peramivir Intermediate from 2021 to 2026.
Chapter 3, the Peramivir Intermediate competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peramivir Intermediate breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Peramivir Intermediate market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Peramivir Intermediate.
Chapter 14 and 15, to describe Peramivir Intermediate sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Peramivir Intermediate. Industry analysis & Market Report on Peramivir Intermediate is a syndicated market report, published as Global Peramivir Intermediate Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Peramivir Intermediate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.